Posts

Lego-like gene editing tool lets researchers improve ca...

SAN FRANCISCO, CA—In recent years, scientists have used gene modification techno...

AI-driven tool makes it easy to personalize 3D-printabl...

As 3D printers have become cheaper and more widely accessible, a rapidly growing...

Nourishing Your Aging Brain: The Power Of Medicinal Mus...

As we journey through life, the aging process brings with it a host of changes, ...

Ahead of the seasonal spike, Pfizer and BioNTech’s Covi...

The U.S. FDA has taken a significant step by approving modified mRNA vaccines fo...

Novo Nordisk’s Wegovy Launch in UK Amid Competition

Novo Nordisk has initiated the rollout of its Wegovy weight loss injection in th...

Arbutus Halts COVID-19 RNA Destabilization Projects Aft...

Arbutus Biopharma has undertaken a substantial shift in its strategic direction,...

Menarini signs agreement for Astellas’s rheumatoid arth...

Menarini Asia-Pacific has entered a long-term exclusive agreement to license Ast...

Dewpoint and Chemify partner for cancer drug discovery

Dewpoint Therapeutics entered a collaboration with Chemify to expedite the disco...

Avalo drops three rare disease assets amid ongoing chal...

The company will divest the AVTX-800 rare disease compound series to AUG Therape...

Results from Rybrevant trial solidify Janssen’s foothol...

Currently, NSCLC patients with EGFR exon 19 deletions or L858R substitution face...

Bristol Myers Squibb’s Reblozyl reinforces market share...

On August 28, the FDA approved the label expansion of Bristol Myers Squibb’s Reb...

FDA to start review of subcutaneous Entyvio for Crohn’s...

The FDA is also reviewing a subcutaneous formulation of Takeda’s blockbuster dru...

FDA calls out eight companies for selling unapproved ey...

The US Food and Drug Administration has sent letters to eight companies for unau...

Vaxess raises $9m to accelerate mRNA vaccine patch deve...

The patch allows for vaccine storage and transport at room temperature along wit...

Do diet drugs pull their weight?

Diet and weight-loss drugs have entered the public consciousness, particularly f...

Signal: Roche to refile subcutaneous Tecentriq with FDA...

Roche planned to launch its new subcutaneous Tecentriq formulation this year, bu...